Institute of Business Management

SPSS ASSIGNMENT

Submitted By:

Muhammad Aurangzaib Alam (7531)

Facilitator:

DR SHAHID AMJAD

1
 Between-Subjects Factors

Value Label N

GENDER 1.00 FEMALE 24

2.00 MALE 24

DRUGS 1.00 CISPLATIN 16

2.00 VINBLASTIN 16

3.00 5-FLOURO 16
URACIL

Descriptive Statistics

Dependent Variable:TUMOUR

GENDER DRUGS Mean Std. Deviation N

FEMALE CISPLATIN 60.0000 5.97614 8

VINBLASTIN 62.5000 6.54654 8

5-FLOURO URACIL 57.5000 7.07107 8

Total 60.0000 6.59380 24

MALE CISPLATIN 67.5000 9.25820 8

VINBLASTIN 66.8750 12.51784 8

5-FLOURO URACIL 40.6250 6.78101 8

Total 58.3333 15.85715 24

Total CISPLATIN 63.7500 8.46562 16

VINBLASTIN 64.6875 9.91106 16

5-FLOURO URACIL 49.0625 10.98768 16

Total 59.1667 12.04307 48

The above table shows mean values of drugs used in males and females.

2
 Levene's Test of Equality of Error Variancesa

Dependent Variable:TUMOUR

F df1 df2 Sig.

1.415 5 42 .239

Tests the null hypothesis that the error variance of the dependent variable is equal across
groups.

The above table shows that according to Levene’s test, the significance level is greater than
0.05, therefore the overall test is not significant, meaning the over all test indicates that there
is no statistically significant difference between effect of all these drugs on tumor size in
both males and females.

. Design: Intercept + GENDER + DRUGS + GENDER * DRUGS

3
 Tests of Between-Subjects Effects

Dependent Variable:TUMOUR

Type III Sum of

Source Squares df Mean Square F Sig.

Corrected Model 3897.917a 5 779.583 11.218 .000

Intercept 168033.333 1 168033.333 2417.953 .000

GENDER 33.333 1 33.333 .480 .492

DRUGS 2457.292 2 1228.646 17.680 .000

GENDER * DRUGS 1407.292 2 703.646 10.125 .000

Error 2918.750 42 69.494

Total 174850.000 48

Corrected Total 6816.667 47

a. R Squared = .572 (Adjusted R Squared = .521)

The above test shows the value of R is 5.2 which means there is a weak correlation.
The value of R close to 1 means a strong correlation.

4
Post Hoc Tests

DRUGS

Multiple Comparisons

Dependent Variable:TUMOUR

95% Confidence Interval

Mean Difference
(I) DRUGS (J) DRUGS (I-J) Std. Error Sig. Lower Bound Upper Bound

Tukey HSD CISPLATIN VINBLASTIN -.9375 2.94733 .946 -8.0980 6.2230

5-FLOURO URACIL 14.6875* 2.94733 .000 7.5270 21.8480

VINBLASTIN CISPLATIN .9375 2.94733 .946 -6.2230 8.0980

5-FLOURO URACIL 15.6250* 2.94733 .000 8.4645 22.7855

5-FLOURO URACIL CISPLATIN -14.6875* 2.94733 .000 -21.8480 -7.5270

VINBLASTIN -15.6250* 2.94733 .000 -22.7855 -8.4645

Scheffe CISPLATIN VINBLASTIN -.9375 2.94733 .951 -8.4169 6.5419

5-FLOURO URACIL 14.6875* 2.94733 .000 7.2081 22.1669

VINBLASTIN CISPLATIN .9375 2.94733 .951 -6.5419 8.4169

5-FLOURO URACIL 15.6250* 2.94733 .000 8.1456 23.1044

5-FLOURO URACIL CISPLATIN -14.6875* 2.94733 .000 -22.1669 -7.2081

VINBLASTIN -15.6250* 2.94733 .000 -23.1044 -8.1456

Based on observed means.

The error term is Mean Square(Error) = 69.494.

*. The mean difference is significant at the .05 level.

The above table shows that effect of 5-fluro uracil is significantly different than both cisplatin and vinblastin
on tumor size in males and females.

5
Spread-versus-Level Plots

The above graph shows that we have an outlier value at point 40.0 of x axis. If this value was not
there, we might have found a corleation. But because of presence of this value we have a wide
spread of data and there is no corealtion.

6
7
The above graph shows that 5-flurouiracil (green line) is effective in decreasing the suize of tumors in males and
all three drugs are not effective in females ( blue line).